Dna Ploidy and S-Phase Fraction in Primary Breast Carcinomas in Relation to Prognostic Factors and Survival for Premenopausal Patients at High Risk for Recurrent Disease

References

• Baildam A. D., Zaloudik J., Howell A., et al. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br. J. Cancer 1987; 55: 553
   PubMed Web of Science ®Google Scholar
• Barlogie B., Raber M. N., Schumann J., et al. Flow cytometry in clinical cancer research. Cancer Res. 1983; 43: 3982
   PubMed Web of Science ®Google Scholar
• Cady B. Total mastectomy and partial axillary dissection. Surg. Clin. North Am. 1973; 53: 313
   PubMed Web of Science ®Google Scholar
• Chassevent A., Daver A., Bertrand G., et al. Comparative flow DNA analysis of different cell suspensions in breast carcinoma. Cytometry 1984; 5: 263
   PubMedGoogle Scholar
• Christensen I., Hartmann N. R., Keiding N., Larsen J. K., Noer H., Vindeløv L. Statistical analysis of DNA distributions from cell populations with partial synchrony. Pulse-Cytophotometry, Part III, D. Lutz. European Press, Gent 1978; 71
   Google Scholar
• Cornelisse C. J., van de Velde C. J. H., Caspers R. J. C., Moolenaar A. J., Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry 1987; 8: 225
   PubMedGoogle Scholar
• Coulson P. B., Thornthwaite J. T., Woolley T. W., Sugarbaker E. V., Seckinger D. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res. 1984; 44: 4187
   PubMed Web of Science ®Google Scholar
• Dowle C. S., Owainati A., Robins A., et al. Prognostic significance of the DNA content of human breast cancer. Br. J. Surg. 1987; 74: 133
   PubMed Web of Science ®Google Scholar
• Dressler L. G., Seamer L. C., Owens M. A., Clark G. M., McGuire W. L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420
   PubMed Web of Science ®Google Scholar
• EORTC Breast Co-operative Group. Revision of the standards for assessment of hormone receptors in human breast cancer. Report of the second EORTC workshop, 16–17 March, 1979, the Netherlands Cancer Institute. Eur. J. Cancer 1980; 16: 1513
   Google Scholar
• Erhardt K., Auer G., Folin A., Silfverswärd C., Skoog L. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma. Am. J. Clin. Oncol. 1986; 9: 83
   PubMed Web of Science ®Google Scholar
• Ewers S.-B., Långström E., Baldetorp B., Killander D. Flowcytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 1984; 5: 408
   PubMedGoogle Scholar
• Fosså S. D., Thorud E., Shoaib M. C., Pettersen E. O., Høie J., Knudsen O. S. DNA flow cytometry in primary breast carcinoma. Acta Pathol. Microbiol. Immunol. Scand. Sect. A. 1984; 92: 475
   PubMedGoogle Scholar
• Friedlander M. L., Hedley D. W., Taylor I. W. Clinical and biological significance of aneuploidy in human tumours. J. Clin. Pathol. 1984; 37: 961
   PubMed Web of Science ®Google Scholar
• Gentili C., Sanfilippo O., Silvestrini R. Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer 1981; 48: 974
   PubMed Web of Science ®Google Scholar
• Hedley D. W., Friedlander M. L., Taylor I. W. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985; 6: 327
   PubMedGoogle Scholar
• Hedley D. W., Rugg C. A., Ng A. B. P., Taylor I. W. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res. 1984; 44: 5395
   PubMed Web of Science ®Google Scholar
• Hedley D. W., Rugg C. A., Gelber R. D. Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res. 1987; 47: 4729
   PubMed Web of Science ®Google Scholar
• Horsfall D. J., Tilley W.D., Orell S. R., Marshall V. R., Cant E. L. M. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br. J. Cancer 1986; 53: 23
   PubMed Web of Science ®Google Scholar
• Jakobsen A., Skovgaard Poulsen H., Lindegaard Madsen E., Ellebæk Petersen S., Summer Hansen H. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content. Acta Radiol. Oncol. 1984; 23: 103
   PubMed Web of Science ®Google Scholar
• Kallioniemi O.-P., Blanco G., Alavaikko M., et al. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br. J. Cancer 1987; 56: 637
   PubMed Web of Science ®Google Scholar
• Kallioniemi O.-P., Hietanen T., Mattila J., Lehtinen M., Lauslahti K., Koivula T. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur. J. Cancer Clin. Oncol. 1987; 23: 277
   PubMedGoogle Scholar
• Levack P. A., Mullen P., Anderson T. J., Miller W. R., Forrest A. P. M. DNA analysis of breast tumour fine needle aspirates using flow cytometry. Br. J. Cancer 1987; 56: 643
   PubMedGoogle Scholar
• McDivitt R. W., Stone K. R., Craig R. B., Meyer J. S. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. Lab. Invest. 1985; 52: 287
   PubMed Web of Science ®Google Scholar
• McDivitt R. W., Stone K. R., Craig R. B., Palmer J. O., Meyer J. S., Bauer W. C. A proposed classification of breast cancer based on kinetic information. Derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer 1986; 57: 269
   PubMed Web of Science ®Google Scholar
• McGuire W. L. Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res. Treat. 1987; 10: 5
   PubMed Web of Science ®Google Scholar
• McGuire W. L., Dressler L. G. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. JNCI 1985; 75: 405
   PubMedGoogle Scholar
• Meckenstock G., Bojar H., Hort W. Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer. Anticancer Res. 1987; 7: 749
   PubMedGoogle Scholar
• Moran R. E., Black M. M., Alpert L., Straus M. J. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer 1984; 54: 1586
   PubMedGoogle Scholar
• Olszewski W., Darzynkiewicz Z., Rosen P. P., Schwartz M. K., Melamed M. R. Flow cytometry of breast carcinoma: 1. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 1981; 48: 980
   PubMed Web of Science ®Google Scholar
• Olszewski W., Darzynkiewicz Z., Rosen P. P., Schwartz M. K., Melamed M. R. Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 1981; 48: 985
   PubMedGoogle Scholar
• Owainati A. A. R., Robins R. A., Hinton C., et al. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br. J. Cancer 1987; 55: 449
   PubMed Web of Science ®Google Scholar
• Raber M. N., Barlogie B., Latreille J., Bedrossian C., Fritsche H., Blumenschein G. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 1982; 3: 36
   PubMedGoogle Scholar
• Silvestrini R., Daidone M. G., Gasparini G. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 1985; 56: 1982
   PubMed Web of Science ®Google Scholar
• Stål O., Klintenberg C., Franzen G., et al. A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer. Breast Cancer Res. Treat. 1986; 7: 15
   PubMedGoogle Scholar
• Stuart-Harris R., Hedley D. W., Taylor I. W., Levene A. L., Smith I. E. Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br. J. Cancer 1985; 51: 573
   PubMed Web of Science ®Google Scholar
• Taylor I. W., Musgrove E. A., Friedlander M. L., Foo M. S., Hedley D. W. The influence of age on the DNA ploidy levels of breast tumours. Eur. J. Cancer Clin. Oncol. 1983; 19: 623
   PubMedGoogle Scholar
• Thorpe S. Steroid receptors in breast cancer. Sources of interlaboratory variation in dextran-charcoal assays. Breast Cancer Res. Treat. 1987; 9: 175
   PubMed Web of Science ®Google Scholar
• Vindeløv L. L., Christensen I. J., Jensen G., Nissen N. I. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry 1983; 3: 332
   PubMedGoogle Scholar
• Vindeløv L. L., Christensen I. J., Nissen N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323
   PubMedGoogle Scholar
• Vindeløv L. L., Christensen I. J., Nissen N. I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983; 3: 328
   PubMedGoogle Scholar